Barriers and facilitators for parents in end-of-life decision-making for neonates at the Neonatal Intensive Care Unit: A qualitative study.


Journal

Palliative medicine
ISSN: 1477-030X
Titre abrégé: Palliat Med
Pays: England
ID NLM: 8704926

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 15 2 2022
medline: 15 4 2022
entrez: 14 2 2022
Statut: ppublish

Résumé

Mortality and end-of-life decision-making can occur in newborns, especially within the Neonatal Intensive Care Unit. For parents, participating in end-of-life decision-making is taxing. Knowledge is lacking on what support is helpful to parents during decision-making. To identify barriers and facilitators experienced by parents in making an end-of-life decision for their infant. Qualitative study using face-to-face semi-structured interviews. We interviewed 23 parents with a child that died after an end-of-life decision at a Neonatal Intensive Care Unit between April and September 2018. Parents stated barriers and facilitators within 4 themes: 1. Clinical knowledge and prognosis; 2. Quality of information provision; 3. Emotion regulation; and 4. Psychosocial environment. Facilitators include knowing whether the prognosis includes long-term negative quality of life, knowing all treatment options, receiving information according to health literacy level, being able to process intense emotions, having experienced counseling and practical help. Barriers include a lack of general medical knowledge, being unprepared for a poor prognosis, having an uninformed psychologist. We found that clinical information and psychosocial support aid parents in decision-making. Information is best tailored to health literacy. Psychosocial support can be provided by experienced, informed counselors, social services and sibling support, distinguishing between verbal and non-verbal coping preferences, and calm, familiar architecture. Intense emotions may hinder absorption of clinical information, therefore interventions to aid emotion regulation and reduce cognitive load may be looked at in further research. Adjustment of the Situations, Opinions and Options, Parents, Information, Emotions framework based on our results can be evaluated.

Sections du résumé

BACKGROUND
Mortality and end-of-life decision-making can occur in newborns, especially within the Neonatal Intensive Care Unit. For parents, participating in end-of-life decision-making is taxing. Knowledge is lacking on what support is helpful to parents during decision-making.
AIM
To identify barriers and facilitators experienced by parents in making an end-of-life decision for their infant.
DESIGN
Qualitative study using face-to-face semi-structured interviews.
SETTING/PARTICIPANTS
We interviewed 23 parents with a child that died after an end-of-life decision at a Neonatal Intensive Care Unit between April and September 2018.
RESULTS
Parents stated barriers and facilitators within 4 themes: 1. Clinical knowledge and prognosis; 2. Quality of information provision; 3. Emotion regulation; and 4. Psychosocial environment. Facilitators include knowing whether the prognosis includes long-term negative quality of life, knowing all treatment options, receiving information according to health literacy level, being able to process intense emotions, having experienced counseling and practical help. Barriers include a lack of general medical knowledge, being unprepared for a poor prognosis, having an uninformed psychologist.
CONCLUSIONS
We found that clinical information and psychosocial support aid parents in decision-making. Information is best tailored to health literacy. Psychosocial support can be provided by experienced, informed counselors, social services and sibling support, distinguishing between verbal and non-verbal coping preferences, and calm, familiar architecture. Intense emotions may hinder absorption of clinical information, therefore interventions to aid emotion regulation and reduce cognitive load may be looked at in further research. Adjustment of the Situations, Opinions and Options, Parents, Information, Emotions framework based on our results can be evaluated.

Identifiants

pubmed: 35152797
doi: 10.1177/02692163221076365
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

730-741

Auteurs

Veerle Piette (V)

End-of-Life Care Research Group, Vrije Universiteit Brussel and Ghent University, Ghent, Belgium.
Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Laure Dombrecht (L)

End-of-Life Care Research Group, Vrije Universiteit Brussel and Ghent University, Ghent, Belgium.
Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Luc Deliens (L)

End-of-Life Care Research Group, Vrije Universiteit Brussel and Ghent University, Ghent, Belgium.
Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Filip Cools (F)

Department of Neonatology, University Hospital Brussels, Vrije Universiteit Brussel, Brussels, Belgium.

Kenneth Chambaere (K)

End-of-Life Care Research Group, Vrije Universiteit Brussel and Ghent University, Ghent, Belgium.
Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Linde Goossens (L)

Department of Neonatology, Ghent University Hospital, Ghent, Belgium.

Gunnar Naulaers (G)

Department of Development and Regeneration, KU Leuven, Leuven.

Sabine Laroche (S)

Department of Neonatology, Antwerp University Hospital, Edegem, Antwerp, Belgium.

Luc Cornette (L)

Department of Neonatology, AZ Sint-Jan Brugge-Oostende, Brugge, Belgium.

Eline Bekaert (E)

Research Department Belgian Poison Centre, Brussels, Belgium.

Pauline Decoster (P)

Department of Maternity, AZ Sint-Jan Brugge-Oostende, Oostende, Belgium.

Kim Beernaert (K)

End-of-Life Care Research Group, Vrije Universiteit Brussel and Ghent University, Ghent, Belgium.
Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

Joachim Cohen (J)

End-of-Life Care Research Group, Vrije Universiteit Brussel and Ghent University, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH